Abstract
Paclitaxel is a chemotherapeutic widely used to treat breast and ovarian cancer. Despite its efficacy against cancer cells, this drug triggers neuropathy in about 70% of the patients. So far, it is known that this drug induces microtubule stabilization and interrupts the axonal transport, leading to ATP impairment and increased oxidative stress. Studies demonstrate a causal correlation be…